Merck KGaA (FRA:MRK)‘s stock had its “neutral” rating reissued by JPMorgan Chase & Co. in a note issued to investors on Thursday.

A number of other analysts have also recently commented on the company. Commerzbank AG set a €101.00 ($108.60) target price on Merck KGaA and gave the stock a “buy” rating in a research report on Thursday, August 4th. Societe Generale set a €97.00 ($104.30) target price on Merck KGaA and gave the stock a “neutral” rating in a research report on Wednesday, November 16th. DZ Bank AG reiterated a “buy” rating on shares of Merck KGaA in a research report on Monday, October 17th. BNP Paribas set a €114.00 ($122.58) target price on Merck KGaA and gave the stock a “buy” rating in a research report on Friday, September 30th. Finally, Citigroup Inc. set a €115.00 ($123.66) target price on Merck KGaA and gave the stock a “buy” rating in a research report on Thursday, September 29th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of €101.91 ($109.58).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Shares of Merck KGaA (FRA:MRK) opened at 95.35 on Thursday. Merck KGaA has a 52 week low of €70.87 and a 52 week high of €100.00. The stock has a 50 day moving average price of €95.54 and a 200-day moving average price of €92.98. The stock has a market cap of €41.50 billion and a P/E ratio of 27.89.

About Merck KGaA

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.